Osteoporosis International

, Volume 23, Issue 11, pp 2577–2577

Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper


  • R. Rizzoli
    • Division of Bone DiseasesGeneva University Hospitals and Faculty of Medicine
  • J. J. Body
    • Department of Medicine, CHU BrugmannUniversité Libre de Bruxelles
  • A. DeCensi
    • Division of Medical OncologyGalliera Hospital
    • Division of Cancer Prevention and GeneticsEuropean Institute of Oncology
  • J. Y. Reginster
    • Department of Public Health ScienceUniversity of Liège
  • P. Piscitelli
    • Department of Internal MedicineUniversity of Florence
    • Department of Internal MedicineUniversity of Florence
  • on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)

DOI: 10.1007/s00198-012-1930-0

Cite this article as:
Rizzoli, R., Body, J.J., DeCensi, A. et al. Osteoporos Int (2012) 23: 2577. doi:10.1007/s00198-012-1930-0

Erratum to: Osteoporos Int

DOI 10.1007/s00198-011-1870-0

The third author’s name was rendered incorrectly. The correct name is A. DeCensi.

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2012